Provided is a pharmaceutical composition for preventing or treating diabetic nephropathy. According to the present invention, a pharmaceutical composition for preventing or treating diabetic nephropathy includes an adenosine derivative compound or a pharmaceutically acceptable salt thereof as an active ingredient.